About LGM Pharma
LGM Pharma is a Healthcare company based in Nashville (United States) founded in 2003, and was acquired by New Harbor Capital in November 2017. Contract manufacturing API services. The company has 174 employees. LGM Pharma has completed 1 acquisition, including Wainwright Associates. Its website lgmpharma.com draws about 20 thousand monthly visits. LGM Pharma offers products and services including API Sourcing, CDMO Services, and Analytical Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is LGM PHARMA LLC.
Company details
LGM Pharma was founded in 2003 and is based in Nashville, United States. Operations focus on the pharmaceutical sector, where contract manufacturing of active pharmaceutical ingredients is conducted for preclinical, clinical, and commercial phases under CGMP standards. Services extend to over-the-counter ingredients, pharmacy compounding, and drug delivery systems, with additional support provided for regulatory compliance and quality assurance.
- Headquarters Nashville, United States
- Employees 174
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website lgmpharma.com
- Social LinkedIn X Facebook
- Acquired by New Harbor Capital (Nov 2017)
- Legal Name Lgm Pharma Llc
- InvestorsCapital Southwest
& 1 more
- Employee Count174
- Investments & Acquisitions
- Acquired byNew Harbor Capital
(Nov 2017)
Products & Services of LGM Pharma
LGM Pharma offers a comprehensive portfolio of products and services, including API Sourcing, CDMO Services, and Analytical Services.
Secures and delivers high-quality APIs from global manufacturers.
Handles formulation development and commercial scale-up for drugs.
Provides analytical testing and stability studies for APIs.
Funding Insights of LGM Pharma
- Total Rounds 2
- Investors Count 1
All 2 funding rounds of LGM Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | Debt – Conventional | – | – | ||
| Nov 2017 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in LGM Pharma
LGM Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Capital Southwest and New Harbor Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm | 1961 | capitalsouthwest.com | Dallas, United States | |
A private equity firm based in Chicago, focused on transforming businesses. | newharborcap.com | Chicago, United States |
Investor details for LGM Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LGM Pharma
23 people are tracked at LGM Pharma (10 in leadership, 13 in team); the tracked headcount is 174.
| Name | Role | Group |
|---|---|---|
Carleen MacNeill | Senior Director Human Resources | Leadership |
Hamilton Lenox | Chief Commercial Officer (cco) | Leadership |
Laurie Hammell | Executive Assistant To CEO & Senior Leadership Team | Leadership |
Georgiana Hennessy | VP Project Management | Leadership |
Richard Goitia | Chief Financial Officer | Leadership |
Shailesh Vengurlekar | Senior Vice President Quality And Regulatory Affairs | Leadership |
Prasad Raje | CEO | Leadership |
Mike Stenberg | Vice President - Business Development | Leadership |
Patrick Tylek | Director Of Business Development | Leadership |
Kathy Kramer | Director Of Quality | Leadership |
Emil Joseph | Senior QC Chemist: Pharmaceutical GMP | Team |
Jun Aihara | Validation/metrology Engineer | Team |
Mason Maupins | Quality Control Chemist | Team |
Angela Jasmin | Accounting Manager | Team |
Raimundo Contreraz | Accounts Payable Specialist | Team |
Luis Fonseca | Accounts Payable & Receivable Specialist | Team |
Robin Doering | Senior Regulatory Affairs Specialist | Team |
Travis Smith | QA Specialist | Team |
Tova Herrmann | Accounting Manager | Team |
Shani Ismach | QA Specialist | Team |
3 more people are available in the full profile.
Complete people profiles for LGM Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LGM Pharma
LGM Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Wainwright Associates.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of healthcare and advisory consulting services | wainwrightassociates.co.uk | Wooburn Green, United Kingdom | 1999 | May 2015 | •••• |
Complete acquisition details for LGM Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LGM Pharma
4 dated milestones of LGM Pharma across 14 years, from founding to its latest funding, stage changes and deals.
- Founded LGM Pharma is founded.
- Acquisition Acquires Wainwright Associates.
- Exit Acquired by New Harbor Capital.
- Funding First funding round.
Web traffic of LGM Pharma
The website of LGM Pharma (lgmpharma.com) receives about 20.1K visits a month and ranks #1,606,485 among all websites worldwide, #2,161 in Biotechnology and Pharmaceuticals.
- Monthly visits20.1K
▲ 9.7% vs previous month
- Unique visitors5.2K
per month
- Global rank#1,606,485
among all websites
- Category rank#2,161
Health · Biotechnology and Pharmaceuticals
- Bounce rate62%
- Pages per visit1.5
- Average visit42 sec
- DevicesDesktop 45% · Mobile 55%
Websites whose visitors overlap most with LGM Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
drug-dev.com | drug-dev.com | 100% | #896,353 | – | |
| patheon.com | 94% | 89.1K | #488,648 | View details | |
| usvindia.com | 86% | 11.4K | #2,386,041 | View details | |
pharmasource.global | pharmasource.global | 81% | #567,063 | – | |
| pharmamanufacturing.com | 81% | #1,938,419 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for LGM Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as LGM Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lgm Pharma
Complete news archive for LGM Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LGM Pharma
LGM Pharma was founded in 2003 and raised its 1st funding round 14 years after it was founded.
LGM Pharma is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
LGM Pharma has 174 employees.
LGM Pharma was founded in 2003 and is based in Nashville, United States. Operations focus on the pharmaceutical sector, where contract manufacturing of active pharmaceutical ingredients is conducted for preclinical, clinical, and commercial phases under CGMP standards. Services extend to over-the-counter ingredients, pharmacy compounding, and drug delivery systems, with additional support provided for regulatory compliance and quality assurance.
LGM Pharma offers API Sourcing, CDMO Services, and Analytical Services.
LGM Pharma has made 1 acquisition, including Wainwright Associates.
LGM Pharma has 2 investors. Key investors include Capital Southwest, and New Harbor Capital.
LGM Pharma operates through Lgm Pharma Llc.
Yes. LGM Pharma was acquired by New Harbor Capital in November 2017.